UNSPSC 51282917: Fandofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C20H18F2N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, I6406OC637 chemically known as 6-fluoro-1-(5-fluoro-2-pyridyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as fandofloxacin, which bears US NIH Compound Identifier 178087. European Medicines Agency schedules Fandofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07508MIG.

UNSPSC 51282917 Fandofloxacin is a Commodity code for a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it do not reflect procurement of fandofloxacin itself. Instead, the records show awards and solicitations for different antibiotics and emergency-response pharmaceuticals—specifically doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone—indicating a mismatch between the code's nominal scope and the work actually being bought by state and local agencies right now. State and local procurement offices are using this code to source bulk pharmaceutical supplies through piggyback contracts with established consortia and competitive bidding for community health and emergency-response initiatives, but fandofloxacin does not appear to be the active product line under current activity.

Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies posting under this code. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for doxycycline hyclate and ciprofloxacin hydrochloride tablets totaling $2,999,999.11 over the initial 12-month term plus two optional renewal years, with an IFB process. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford. Activity in this code is concentrated in the South and Midwest, with no indication of broader geographic demand. The code shows little relevant recent activity aligned to its fandofloxacin name, making pursuit unlikely unless vendor capability in related antibiotic or emergency-pharmaceutical supply chains is the actual business driver.